Exvivo non-invasive assessment of cell viability and proliferation in bio-engineered whole organ constructs

Biomaterials

Volumn 52, Issue 1, 2015, Pages 103-112

  Ren, Xi ^a,b   Tapias, Luis F ^a,b   Jank, Bernhard J ^a,b   Mathisen, Douglas J ^a,b   Lanuti, Michael ^a,b   Ott, Harald C ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Decellularization; Organ regeneration; Perfusion; Resazurin; Tissue engineering; Viability

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; CELLS; NONINVASIVE MEDICAL PROCEDURES; TISSUE ENGINEERING;

DECELLULARIZATION; ORGAN REGENERATION; PERFUSION; RESAZURIN; VIABILITY;

SCAFFOLDS (BIOLOGY);

RESAZURIN; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; OXAZINE DERIVATIVE; XANTHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CANCER CELL CULTURE; CELL COUNT; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM; EX VIVO STUDY; HISTOLOGY; HUMAN; HUMAN CELL; MALE; NON INVASIVE PROCEDURE; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; TISSUE PERFUSION; TISSUE SCAFFOLD; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; ENDOTHELIAL PROGENITOR CELL; LUNG; LUNG TUMOR; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PERFUSION; PHYSIOLOGY; PROCEDURES; REGENERATION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BIOENGINEERING; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL PROGENITOR CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INDICATORS AND REAGENTS; LUNG; LUNG NEOPLASMS; MALE; ORGAN CULTURE TECHNIQUES; OXAZINES; PERFUSION; RATS, SPRAGUE-DAWLEY; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS; XANTHENES;

EID: 84932639149     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.01.061     Document Type: Article

References (44)

1. Ott H.C., Matthiesen T.S., Goh S.-K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221.
2. Badylak S.F., Taylor D., Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011, 13:27-53.
3. Ren X., Ott H.C. On the road to bioartificial organs. Pflugers Arch - Eur J Physiol 2014, 1-11.
4. Ott H.C., Clippinger B., Conrad C., Schuetz C., Pomerantseva I., Ikonomou L., et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010, 16:927-933.
5. Petersen T.H., Calle E.A., Zhao L., Lee E.J., Gui L., Raredon M.B., et al. Tissue-engineered lungs for invivo implantation. Science 2010, 329:538-541.
6. Uygun B.E., Soto-Gutierrez A., Yagi H., Izamis M.-L., Guzzardi M.A., Shulman C., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010, 16:814-820.
7. Song J.J., Guyette J.P., Gilpin S.E., Gonzalez G., Vacanti J.P., Ott H.C. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013, 19:646-651.
8. Mishra D.K., Thrall M.J., Baird B.N., Ott H.C., Blackmon S.H., Kurie J.M., et al. Human lung cancer cells grown on acellular rat lung matrix create perfusable tumor nodules. Ann Thorac Surg 2012, 93:1075-1081.
9. Shen Y.H., Shoichet M.S., Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 2008, 4:477-489.
10. Radisic M., Euloth M., Yang L., Langer R., Freed L.E., Vunjak-Novakovic G. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng 2003, 82:403-414.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. JImmunol Methods 1983, 65:55-63.
12. Sherwood J.K., Riley S.L., Palazzolo R., Brown S.C., Monkhouse D.C., Coates M., et al. Athree-dimensional osteochondral composite scaffold for articular cartilage repair. Biomaterials 2002, 23:4739-4751.
13. Zund G., Ye Q., Hoerstrup S.P., Schoeberlein A., Schmid A.C., Grunenfelder J., et al. Tissue engineering in cardiovascular surgery: MTT, a rapid and reliable quantitative method to assess the optimal human cell seeding on polymeric meshes. Eur J Cardio Thoracic Surg 1999, 15:519-524.
14. Lü L., Zhang L., Wai M.S.M., Yew D.T.W., Xu J. Exocytosis of MTT formazan could exacerbate cell injury. Toxicol Vitro 2012, 26:636-644.
15. Roehm N.W., Rodgers G.H., Hatfield S.M., Glasebrook A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. JImmunol Methods 1991, 142:257-265.
16. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988, 48:4827-4833.
17. Riss T.L., Moravec R.A., Niles A.L., Benink H.A., Worzella T.J., Minor L. Assay guidance manual: cell viability assays 2004, Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda (MD).
18. O'Brien J., Wilson I., Orton T., Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000, 267:5421-5426.
19. Wesierska-Gadek J., Gueorguieva M., Ranftler C., Zerza-Schnitzhofer G. Anew multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death. JCell Biochem 2005, 96:1-7.
20. Mueller D., Tascher G., Damm G., Nüssler A., Heinzle E., Noor F. Real-time in situ viability assessment in a 3D bioreactor with liver cells using resazurin assay. Cytotechnology 2013, 65:297-305.
21. Gloeckner H., Jonuleit T., Lemke H.-D. Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue™. JImmunol Methods 2001, 252:131-138.
22. Zhou X., Holsbeeks I., Impens S., Sonnaert M., Bloemen V., Luyten F., et al. Noninvasive real-time monitoring by AlamarBlue® during invitro culture of three-dimensional tissue-engineered bone constructs. Tissue Eng Part C Methods 2013, 19:720-729.
23. van Gaalen S.M., de Bruijn J.D., Wilson C.E., van Blitterswijk C.A., Verbout A.J., Alblas J., et al. Relating cell proliferation to invivo bone formation in porous Ca/P scaffolds. JBiomed Mater Res Part A 2010, 92A:303-310.
24. Caralt M., Uzarski J.S., Iacob S., Obergfell K.P., Berg N., Bijonowski B.M., et al. Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant 2015, 15:64-75.
25. Boncler M., Rózalski M., Krajewska U., Podsedek A., Watala C. Comparison of PrestoBlue and MTT assays of cellular viability in the assessment of anti-proliferative effects of plant extracts on human endothelial cells. JPharmacol Toxicol Methods 2014, 69:9-16.
26. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
27. Melero-Martin J.M., Khan Z.A., Picard A., Wu X., Paruchuri S., Bischoff J. Invivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109:4761-4768.
28. Au P., Daheron L.M., Duda D.G., Cohen K.S., Tyrrell J.A., Lanning R.M., et al. Differential invivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111:1302-1305.
29. Guyette J.P., Gilpin S.E., Charest J.M., Tapias L.F., Ren X., Ott H.C. Perfusion decellularization of whole organs. Nat Protoc 2014, 9:1451-1468.
30. Wagner B.A., Venkataraman S., Buettner G.R. The rate of oxygen utilization by cells. Free Radic Biol Med 2011, 51:700-712.
31. Sabater D., Arriarán S., Romero MdM., Agnelli S., Remesar X., Fernández-López J.A., et al. Cultured 3T3L1 adipocytes dispose of excess medium glucose as lactate under abundant oxygen availability. Sci Rep 2014, 4:3663.
32. Bittner C.X., Loaiza A., Ruminot I., Larenas V., Sotelo-Hitschfe T., Gutiérrez R., et al. High resolution measurement of the glycolytic rate. Front Neuroenergetics 2010, 2:26.
33. Zhang F., Tian J., Wang L., He P., Chen Y. Correlation between cell growth rate and glucose consumption determined by electrochemical monitoring. Sensors Actuators B: Chem 2011, 156:416-422.
34. O'Brien F.J., Harley B.A., Yannas I.V., Gibson L.J. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 2005, 26:433-441.
35. Amini A.R., Adams D.J., Laurencin C.T., Nukavarapu S.P. Optimally porous and biomechanically compatible scaffolds for large-area bone regeneration. Tissue Eng Part A 2012, 18:1376-1388.
36. Chiu L.L.Y., Weisel R.D., Li R.-K., Radisic M. Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. JTissue Eng Regen Med 2011, 5:69-84.
37. Chiu L.L.Y., Radisic M. Scaffolds with covalently immobilized VEGF and angiopoietin-1 for vascularization of engineered tissues. Biomaterials 2010, 31:226-241.
38. Govoni M., Muscari C., Guarnieri C., Giordano E. Mechanostimulation protocols for cardiac tissue engineering. BioMed Res Int 2013, 2013:918640.
39. Tandon N., Cannizzaro C., Chao P.-H.G., Maidhof R., Marsano A., Au H.T.H., et al. Electrical stimulation systems for cardiac tissue engineering. Nat Protoc 2009, 4:155-173.
40. Kuramochi Y., Guo X., Sawyer D.B., Lim C.C. Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes. Exp Physiol 2006, 91:773-780.
41. Kohn D.F., Clifford C.B. Chapter 4 - biology and diseases of rats. Laboratory animal medicine 2002, 121-165. Academic Press, Burlington. 2nd ed. J.G. Fox, L.C. Anderson, F.M. Loew, F.W. Quimby (Eds.).
42. Larson E.M., Doughman D.J., Gregerson D.S., Obritsch W.F. Anew, simple, nonradioactive, nontoxic invitro assay to monitor corneal endothelial cell viability. Investig Ophthalmol Vis Sci 1997, 38:1929-1933.
43. Ansar Ahmed S., Gogal R.M., Walsh J.E. Anew rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. JImmunol Methods 1994, 170:211-224.
44. Nakayama G.R., Caton M.C., Nova M.P., Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability invitro. JImmunol Methods 1997, 204:205-208.